94 related articles for article (PubMed ID: 19831134)
21. Knockdown of EphB1 receptor decreases medulloblastoma cell growth and migration and increases cellular radiosensitization.
Bhatia S; Baig NA; Timofeeva O; Pasquale EB; Hirsch K; MacDonald TJ; Dritschilo A; Lee YC; Henkemeyer M; Rood B; Jung M; Wang XJ; Kool M; Rodriguez O; Albanese C; Karam SD
Oncotarget; 2015 Apr; 6(11):8929-46. PubMed ID: 25879388
[TBL] [Abstract][Full Text] [Related]
22. Extracellular matrix concentration exerts selection pressure on invasive cells.
Perumpanani AJ; Byrne HM
Eur J Cancer; 1999 Aug; 35(8):1274-80. PubMed ID: 10615241
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of FOXM1 by thiostrepton sensitizes medulloblastoma to the effects of chemotherapy.
Lin J; Zheng Y; Chen K; Huang Z; Wu X; Zhang N
Oncol Rep; 2013 Oct; 30(4):1739-44. PubMed ID: 23912794
[TBL] [Abstract][Full Text] [Related]
24. Equivalence of hyperfractionated and continuous brachytherapy in a rat tumor model and remarkable effectiveness when preceded by external irradiation.
Veninga T; Visser AG; van den Berg AP; van Hooije CM; van Geel CA; Levendag PC
Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1351-60. PubMed ID: 11286843
[TBL] [Abstract][Full Text] [Related]
25. [Time factor and repopulation during fractionated radiotherapy. Comparison between two xenografted human squamous cell carcinoma].
Hesselmann S; Lindel K; Horn K; Könemann S; Schuck A; Willich N; Rübe C
Strahlenther Onkol; 2003 Jan; 179(1):38-44. PubMed ID: 12540983
[TBL] [Abstract][Full Text] [Related]
26. Changes in tumor cell response due to prolonged dose delivery times in fractionated radiation therapy.
Paganetti H
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):892-900. PubMed ID: 16199319
[TBL] [Abstract][Full Text] [Related]
27. Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation.
Yaromina A; Krause M; Thames H; Rosner A; Krause M; Hessel F; Grenman R; Zips D; Baumann M
Radiother Oncol; 2007 Jun; 83(3):304-10. PubMed ID: 17517444
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma.
Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK
Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617
[TBL] [Abstract][Full Text] [Related]
29. In Vitro and In Vivo Characterization of a Preclinical Irradiation-Adapted Model for Ewing Sarcoma.
Shapiro MC; Tang T; Dasgupta A; Kurenbekova L; Shuck R; Gaber MW; Yustein JT
Int J Radiat Oncol Biol Phys; 2018 May; 101(1):118-127. PubMed ID: 29534895
[TBL] [Abstract][Full Text] [Related]
30. Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy.
Prados MD; Wara W; Edwards MS; Ater J; Rabbit J; Lamborn K; Davis R; Levin VA
Pediatr Neurosurg; 1996 Oct; 25(4):174-81. PubMed ID: 9293544
[TBL] [Abstract][Full Text] [Related]
31. Role of Rac1-regulated signaling in medulloblastoma invasion. Laboratory investigation.
Zavarella S; Nakada M; Belverud S; Coniglio SJ; Chan A; Mittler MA; Schneider SJ; Symons M
J Neurosurg Pediatr; 2009 Aug; 4(2):97-104. PubMed ID: 19645540
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the effectiveness of tirapazamine and carbogen with nicotinamide in enhancing the response of a human tumor xenograft to fractionated irradiation.
el-Said A; Menke D; Dorie MJ; Brown JM
Radiat Oncol Investig; 1999; 7(3):163-9. PubMed ID: 10406058
[TBL] [Abstract][Full Text] [Related]
33. Influence of scheduling, dose, and volume of administration of a perfluorochemical emulsion on tumor response to radiation therapy.
Teicher BA; Herman TS; Jones SM
Int J Radiat Oncol Biol Phys; 1990 Oct; 19(4):945-51. PubMed ID: 2211263
[TBL] [Abstract][Full Text] [Related]
34. Comparable cell survival between high dose rate flattening filter free and conventional dose rate irradiation.
Verbakel WF; van den Berg J; Slotman BJ; Sminia P
Acta Oncol; 2013 Apr; 52(3):652-7. PubMed ID: 23126524
[TBL] [Abstract][Full Text] [Related]
35. Cancer risk from low dose radiation in Ptch1
Tanori M; Pannicelli A; Pasquali E; Casciati A; Antonelli F; Giardullo P; Leonardi S; Tanno B; De Stefano I; Saran A; Mancuso M; Pazzaglia S
DNA Repair (Amst); 2019 Feb; 74():70-79. PubMed ID: 30606609
[TBL] [Abstract][Full Text] [Related]
36. Medulloblastoma--prognostic factors and outcome of treatment: review of the Mayo Clinic experience.
Garton GR; Schomberg PJ; Scheithauer BW; Shaw EG; Ilstrup DM; Blackwell CR; Laws ER; Earle JD
Mayo Clin Proc; 1990 Aug; 65(8):1077-86. PubMed ID: 2117687
[TBL] [Abstract][Full Text] [Related]
37. Anti-proliferative activity of the quassinoid NBT-272 in childhood medulloblastoma cells.
von Bueren AO; Shalaby T; Rajtarova J; Stearns D; Eberhart CG; Helson L; Arcaro A; Grotzer MA
BMC Cancer; 2007 Jan; 7():19. PubMed ID: 17254356
[TBL] [Abstract][Full Text] [Related]
38. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
[TBL] [Abstract][Full Text] [Related]
39. Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signaling.
Fisher KE; Pop A; Koh W; Anthis NJ; Saunders WB; Davis GE
Mol Cancer; 2006 Dec; 5():69. PubMed ID: 17156449
[TBL] [Abstract][Full Text] [Related]
40. Recovery from sublethal damage during fractionated irradiation of human FaDu SCC.
Petersen C; Zips D; Krause M; Völkel W; Thames HD; Baumann M
Radiother Oncol; 2005 Mar; 74(3):331-6. PubMed ID: 15763315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]